市场调查报告书
商品编码
1530864
2030 年整形外科器械市场预测:按产品类型、材料类型、分销管道、最终用户和地区进行的全球分析Orthopedic Devices Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Distribution Channel, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球整形外科器械市场规模为 637 亿美元,预计到 2030 年将达到 878 亿美元,预测期内复合年增长率为 5.5%。整形外科器械用于识别、治疗和预防影响肌肉骨骼系统的疾病,肌肉骨骼系统由骨骼、关节、韧带、肌腱和肌肉组成。这些器械对于治疗各种整形外科疾病至关重要,包括先天性畸形、关节炎、骨折和运动伤害。这些范围从简单的矫正器具和夹板到复杂的外科植入,如髋关节置换术和脊椎融合装置。整形外科器械不仅可以帮助患者恢復功能和活动能力,还可以透过减轻疼痛和改善生活品质来帮助他们过上更好的生活。
根据世界卫生组织 (WHO) 预测,到 2050 年,全球 60 岁及以上人口预计将达到 21 亿。
慢性病增加
该市场直接受到糖尿病和肥胖等慢性病全球成长的影响。骨关节炎在肥胖者中更为常见,因为肥胖会增加关节的机械负荷,尤其是膝盖和臀部。糖尿病与夏科足等併发症有关,夏科足会削弱足部骨骼,需要进行整形外科手术。此外,生活方式的改变增加了这些慢性病的盛行率,增加了对整形外科治疗的需求,例如增加活动能力的脊椎装置、关节重建和疼痛管理。
设备开发高成本
开发先进的整形外科设备需要在研究、临床试验和监管核准方面进行大量投资。为了确保安全性和有效性,对最尖端科技和材料的需求加剧了这种经济负担。此外,严格的监管标准需要大量的测试,进一步增加了成本。这些高昂的开发成本可能会限制新公司的市场进入、减少创新并导致最终用户的价格上涨,进而影响整体市场成长。
自订植入和个人化医疗的开发
由于个人化医疗的趋势,市场正在扩大。 3D 列印和成像技术的进步使得创建适合患者独特解剖结构的自订植入成为可能。透过这种个人化方法,可以实现更好的手术效果、更快的恢復时间和更高的患者满意度。此外,与患者骨骼结构精确匹配的客製化膝关节和髋植入可以延长设备寿命并降低植入失败的风险。随着这些技术的进一步发展,将有更多的商业机会来开发和销售客製化整形外科解决方案。
强大的价格压力和市场竞争
术后併发症对整形外科器械市场构成重大威胁,影响病患復健并增加医疗成本。感染疾病、植入失败和副作用等问题可能导致住院时间延长、额外手术和发病率增加。这些併发症不仅影响病患的治疗效果,也影响整形外科器械製造商的声誉和财务表现。
由于医疗保健系统专注于应对 COVID-19 病例激增,推迟了关节关节重建等非紧急整形外科手术,这推动了整形外科器械市场在 COVID-19 大流行期间的上涨,这对市场产生了巨大影响。结果,在疫情最严重的时候,整形外科器械市场出现了显着下降。此外,供应链中断进一步复杂化了生产和分销,影响了零件和原材料的可用性。
预计联合重组设备领域在预测期内将是最大的。
在整形外科器械市场中,联合重组器械细分市场占据最大的市场占有率。随着骨关节炎、类风湿性关节炎等关节相关疾病越来越常见,尤其是人口老化,髋关节、膝关节关节重建等关节重建置换术的需求量很大,这也是其优越性的主要原因。此外,关节重组技术的开拓,包括开发更俱生物相容性和持久性的材料、微创手术的采用以及自订植入的日益普及,正在推动该市场的进一步成长。
预计聚合物产业在预测期内复合年增长率最高。
预计在预测期内,聚合物细分市场将在整形外科市场中实现最高的年复合成长率。这种增长是由于先进聚合物材料由于其卓越的生物相容性、灵活性和耐用性而在整形外科植入和设备中越来越多地采用所推动的。聚合物技术的创新有助于开发轻质、高效能的设备,进而改善患者的治疗效果。此外,对微创外科手术的需求不断增长以及世界人口的老化进一步促进了这一领域的快速扩张。
北美在整形外科器械市场中占最大份额。该地区整形外科疾病盛行率高、医疗研发投入庞大、医疗基础设施完善是该地区优势的关键因素。美国人口老化、医疗保健系统发达以及对尖端整形外科解决方案的高需求,是这一份额的主要贡献者。此外,顶级整形外科器械製造商的存在和保险计划的大力支持进一步加强了北美的市场领导地位。
整形外科器械市场以亚太地区最高的复合年增长率扩张。造成这种快速成长的因素有很多,包括人口成长、整形外科疾病发生频率的增加以及中国和印度等国家医疗保健系统的发展。该地区对整形外科器械需求的增加也归因于医疗设施的发展、医疗保健成本的上升以及对整形外科健康的更好了解。此外,亚太市场的显着成长轨迹也归功于国际参与者的涌入。
According to Stratistics MRC, the Global Orthopedic Devices Market is accounted for $63.7 billion in 2024 and is expected to reach $87.8 billion by 2030, growing at a CAGR of 5.5% during the forecast period. Orthopedic devices are used to identify, treat, and prevent diseases that impact the musculoskeletal system, which is made up of the bones, joints, ligaments, tendons, and muscles. These tools are vital for treating a wide range of orthopedic ailments, including congenital malformations, arthritis, fractures, and sports injuries. Simple braces and splints to intricate surgical implants like hip replacements and spinal fusion machines are among them. Orthopedic devices help patients live better lives by reducing pain and enhancing their quality of life, in addition to helping them regain function and mobility.
According to the World Health Organization (WHO), the global population aged 60 years and older is expected to reach 2.1 billion by 2050.
Growing rate of chronic illnesses
The market is directly impacted by the rise in chronic illnesses like diabetes and obesity that are occurring worldwide. Osteoarthritis is more common in obese people because obesity increases the mechanical load on joints, especially the knees and hips. Diabetes has been linked to complications like Charcot foot, a condition where the foot's bones weaken and necessitate orthopedic device surgery. Additionally, the prevalence of these chronic conditions is rising as a result of changes in lifestyle, and this is driving up demand for orthopedic treatments like spinal devices, joint replacement surgery, and pain management to increase mobility.
High costs of device development
Developing advanced orthopedic devices involves substantial investments in research, clinical trials, and regulatory approvals. This financial burden is amplified by the need for cutting-edge technology and materials to ensure safety and efficacy. Additionally, stringent regulatory standards necessitate extensive testing, further increasing costs. These high development expenses can limit market entry for new companies, reduce innovation, and lead to higher prices for end-users, thereby impacting overall market growth.
Developments in custom implants and personalized medicine
The market is expanding due to the trend toward personalized medicine. Custom implants that are made to fit each patient's unique anatomy are now possible, due to developments in 3D printing and imaging technologies. Better surgical results, quicker recovery periods, and increased patient satisfaction are all possible with this individualized approach. Additionally, bespoke knee and hip implants that precisely match the bone structure of the patient can lengthen the device's lifespan and lower the risk of implant failure. Opportunities for businesses to create and sell customized orthopedic solutions will increase as these technologies develop further.
Strong pricing pressures and market competition
Post-surgical complications pose a significant threat to the orthopedic devices market, impacting patient recovery and increasing healthcare costs. Issues such as infections, implant failures, and adverse reactions can lead to prolonged hospital stays, additional surgeries, and increased morbidity. These complications not only hinder patient outcomes but also affect the reputation and financial performance of orthopedic device manufacturers.
The postponement of elective surgeries, such as joint replacements and other non-emergency orthopedic procedures, as healthcare systems concentrated on managing the surge of COVID-19 cases, had a significant impact on the orthopedic devices market during the COVID-19 pandemic. As a result, at the height of the pandemic, there was a notable drop in the market for orthopedic devices. Moreover, production and distribution were made even more difficult by supply chain interruptions, which also had an impact on the availability of components and raw materials.
The joint reconstruction devices segment is expected to be the largest during the forecast period
In the orthopedic devices market, the joint reconstruction devices segment has the largest market share. As osteoarthritis, rheumatoid arthritis, and other joint-related disorders are becoming more common, especially in the aging population, there is a high demand for joint replacement surgeries, such as hip and knee replacements, which is the main cause of this dominance. Additionally, this market has grown even more as a result of technological developments in joint reconstruction, such as the creation of biocompatible and longer-lasting materials, the use of less invasive surgery, and the increasing popularity of customized implants.
The polymers segment is expected to have the highest CAGR during the forecast period
The polymers segment is anticipated to achieve the highest compound annual growth rate in the orthopedic devices market during the forecast period. This growth is driven by the increasing adoption of advanced polymer materials in orthopedic implants and devices due to their superior biocompatibility, flexibility, and durability. Innovations in polymer technology enable the development of lightweight, high-performance devices that enhance patient outcomes. Additionally, the rising demand for minimally invasive surgical procedures and the aging global population further contribute to the segment's rapid expansion.
In the orthopedic devices market, North America commands the largest share. The region's high incidence of orthopedic disorders, substantial investment in medical R&D, and sophisticated healthcare infrastructure are the main factors contributing to its dominance. With a large aging population, a strong healthcare system, and a high demand for cutting-edge orthopedic solutions, the U.S. in particular contributes significantly to this share. Moreover, the market leadership of North America is further strengthened by the existence of top orthopedic device manufacturers and robust support from insurance systems.
The orthopedic devices market is expanding at the highest CAGR in the Asia-Pacific region. Numerous factors, such as the growing population, the rise in the frequency of orthopedic conditions, and the development of the healthcare system in nations like China and India, are responsible for this quick growth. The rise in demand for orthopedic devices in the area is also attributed to the development of healthcare facilities, the rising cost of medical care, and a greater understanding of orthopedic health. Furthermore, the remarkable growth trajectory of the Asia-Pacific market can also be attributed to the influx of international players.
Key players in the market
Some of the key players in Orthopedic Devices market include Arthrex, B. Braun Melsungen AG, Conmed Corporation, Enovis Corporation, Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Johnson & Johnson (DePuy Synthes), Medtronic plc, NuVasive, Orthofix, OrthoPediatrics, Ossur, Paragon 28, Smith & Nephew, Stryker Corporation, Think Surgical and Zimmer Biomet.
In September 2023, Globus Medical Inc. GMED recently announced that it has successfully closed the previously announced merger with NuVasive. The combined firm will offer one of the most extensive selections of musculoskeletal procedural solutions, enabling technology to influence the care continuum for surgeons and patients.
In September 2023, US-based orthopedics company Enovis has announced plans to acquire surgical implant maker LimaCorporate S.p.A (Lima), to expand its global reach and portfolio of products. Under the terms of the agreement, Enovis will obtain Italy-based Lima in a transaction valued at €800 million ($847 million) made up of a cash payment of €700 million, and €100 million in shares of Enovis common stock, issued within 18 months after closing.
In June 2023, Arterex, a medical device contract manufacturer, has signed an agreement to acquire NextPhase Medical Devices for an undisclosed amount. NextPhase is a class II and III medical device contract manufacturer of complex electromechanical devices, active implantable devices, and single use disposables in North America.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.